Company / Operating Income per Share
Exelixis Operating Income per Share History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Operating Income per Share
$3.10
FY2025
5-year range
$0.35 / $3.10
FY2021-FY2025
Trend
+55.0%
vs FY2024
Sector context
#21 of 201
Health Care
What the data says
Among 201 Health Care companies, Exelixis is in the top 10% for operating income per share. Operating Income per Share has increased for 3 consecutive years, from $0.35 in FY2022 to $3.10 in FY2025.
Based on SEC 10-K filings.
3.10 in FY2025 with a 5-year CAGR of +53.7%. Top quartile in the Health Care sector.
Improved from $0.53 to $3.10 over the past 2 years.
Health Care sector context is included.
Operating Income per Share over time
Growth rates
- 3-Year CAGR
- +107.8%
- 5-Year CAGR
- +53.7%
- 10-Year CAGR
- -
Sector benchmark
+195.7% above sector average
Key checks
Key Insights
- Exelixis's operating income per share has grown for 3 consecutive years.
- In FY2025, operating income per share increased 55.0% year-over-year.
- Ranks #21 out of 201 companies in the Health Care sector.
- Lowest operating income per share in the period was in FY2016.
Company context
Key Data Points
- Altman Z-Score 3.33 (safe zone, above 2.9 threshold)
- Strong profit margin: 29.6%
- High earnings quality (cash-backed earnings)
- Strong return on equity: 31.4%
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Operating Income per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $3.10 | +55.0% |
| FY2024 | $2.00 | +278.5% |
| FY2023 | $0.53 | +52.8% |
| FY2022 | $0.35 | -70.9% |
| FY2021 | $1.19 | +228.4% |
| FY2020 | $0.36 | -70.7% |
| FY2019 | $1.23 | +1397.7% |
| FY2018 | -$0.09 | -116.6% |
| FY2017 | $0.57 | +563.8% |
| FY2016 | -$0.12 | +80.1% |
As of FY2025 · SEC 10-K · Updated Jun 30, 2026